Skip to main content

Table 1 Frequency discovery in 163 patients with a diagnosis of cancer

From: Amplitude-modulated electromagnetic fields for the treatment of cancer: Discovery of tumor-specific frequencies and assessment of a novel therapeutic approach

Tumor type

Number of patients

Number of frequency detection sessions

Number of frequencies

Tumor-specific frequencies

Nb and (%)

Frequencies common to two or more tumor types

Brain tumors

8

22

57

41 (71.9)

16

Hematologic malignancies

7

13

56

44 (78.6)

12

Colorectal cancer

19

40

99

67 (67.7)

32

Hepatocellular carcinoma

46

63

170

144 (84.7)

26

Pancreatic cancer

6

44

162

125 (77.2)

37

Ovarian cancer

10

66

278

219 (78.8)

59

Breast cancer

32

93

188

141 (75.0)

47

Prostate cancer

17

80

187

150 (80.2)

37

Lung cancer

6

17

80

57 (71.3)

23

Renal cell cancer

2

3

36

33 (91.7)

3

Thyroid cancer

1

14

112

89 (79.5)

23

Neuroendocrine tumor

5

5

30

17 (56.7)

13

Bladder cancer

2

4

31

25 (80.6)

6

Leiomyosarcoma

1

2

36

31 (86.1)

5

Thymoma

1

1

2

0 N/A

2

Total

163

467

1524

1183 (77.6)

341

  1. The following frequencies were common to most patients with a diagnosis of breast cancer, hepatocellular carcinoma, prostate cancer and pancreatic cancer: 1873.477 Hz, 2221.323 Hz, 6350.333 Hz and 10456.383 Hz